CPC Pathway Editorial Team · Updates · 2026-10-16
The annual ICD-10-CM code update takes effect on October 1 each calendar year with zero grace period from CMS, commercial clearinghouses, or Medicare Administrative Contractors (MACs). Submitting a deleted code on or after October 1 results in immediate front-end clearinghouse rejections, while failing to adopt newly expanded diagnostic specificity causes downstream revenue loss in CMS-HCC risk adjustment and medical necessity denials.
Official Regulatory Effective Date Notice
The FY 2026 ICD-10-CM Code Set is developed and approved by the CDC National Center for Health Statistics (NCHS) and the Centers for Medicare & Medicaid Services (CMS). All new, revised, and invalidated codes become legally binding under HIPAA for dates of service spanning October 1, 2025 through September 30, 2026.
The 2026 update cycle introduces hundreds of discrete modifications across the 21 chapters of the International Classification of Diseases, Tenth Revision, Clinical Modification. The additions focus heavily on capturing clinical granularity for metabolic hepatic disease, acute cardiovascular decompensation, pediatric eating disorders, and expanded Social Determinants of Health (SDOH).
| Clinical Area | Previous 2025 Reporting | 2026 New / Expanded Subcategories | RCM & Risk Adjustment Impact |
|---|---|---|---|
| 1. Liver Disease (MASH / MASLD) | K76.0 (Fatty liver) or K75.81 (NASH) | K76.01 (MASLD), K76.02 (MASH without fibrosis), K76.03 (MASH with fibrosis) | Direct CMS-HCC V28 risk score mapping; eliminates generic hepatic denials. |
| 2. Heart Failure Stages | I50.- (Systolic/Diastolic only) | I50.82 (Biventricular HF), I50.83 (End-stage heart failure requiring MCS) | Critical for inpatient MS-DRG severity of illness (MCC/CC status). |
| 3. Social Determinants of Health (SDOH) | Z59.1 (Inadequate housing) | Z59.10–Z59.19 (Environmental hazards, lead paint, lack of running water, HVAC failure) | Required reporting for ACO REACH and Medicaid managed care quality incentives. |
| 4. Neoplasm-Related Fatigue & Cognitive Decline | G93.39 (Other postviral fatigue) / R41.84 | G93.33 (Cancer-related fatigue), G93.34 (Chemotherapy-induced cognitive impairment) | Justifies physical therapy, occupational therapy, and palliative care encounters. |
| 5. Lymphoma Histology Specificity | C85.8- (Other specified types) | C85.8A–C85.8J (Specific nodal vs. extranodal subtypes) | Determines prior authorization clearance for targeted oncology biologics. |
| 6. Sepsis Sequelae & Post-Sepsis Syndrome | A41.9 / R65.20 without sequelae code | G93.45 (Post-sepsis syndrome) | Eliminates inappropriate query cycles regarding active vs. historical sepsis. |
| 7. Eating Disorders Granularity | F50.8 (Other eating disorders) | F50.83 (ARFID - Avoidant/Restrictive Food Intake Disorder), F50.84 (Pica in adults) | Substantiates intensive outpatient behavioral health and nutritional therapy. |
| 8. Spinal Disc Degeneration Laterality | M51.36 (Lumbar disc degeneration) | M51.360–M51.369 (Distinguishing with vs. without radiculopathy and exact lumbar level) | Prevents surgical denials for spinal decompression and disc arthroplasty. |
| 9. Pediatric Congenital Anomalies | Q87.89 (Other congenital malformations) | Q87.83 (Genetic aortic aneurysm syndromes including Loeys-Dietz) | Supports genetic testing and multi-specialty surveillance coverage. |
| 10. Presumption of Obesity Severity | E66.01 alone without BMI correlation | E66.811–E66.819 (Obesity class I, class II, and class III with alveolar hypoventilation) | Mandatory clinical predicate for GLP-1 receptor agonist drug authorizations. |
The most consequential diagnostic update for internal medicine, gastroenterology, and risk adjustment is the replacement of non-alcoholic fatty liver disease (NAFLD/NASH) terminology with Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).
International multi-society consensus updated this nomenclature because "non-alcoholic" was deemed both stigmatizing and diagnostically imprecise. In the 2026 Tabular List, coders will no longer default to category K76.0 without verifying whether documentation indicates metabolic dysfunction. Capturing MASH with bridging fibrosis (K76.03) directly impacts clinical risk profiling under MEAT Criteria for HCC Coding.
Every time CMS expands code categories, dozens of instructional notes are modified, added, or relocated. Tabular instructions such as Code Also, Code First, and Excludes1 determine whether secondary diagnoses survive payer automated edits.
Coders must pay close attention when reporting new 2026 conditions alongside chronic systemic diseases. Submitting mutually exclusive codes without understanding official exceptions will trigger unbundling audits. For an in-depth operational walkthrough on navigating instructional prohibitions, read our clinical breakdown on Why CMS Just Changed an Excludes1 Note: The ICD-10-CM Guideline Trap.
Clean revenue cycle execution requires synchronizing your diagnostic ICD-10-CM updates (which occur annually on October 1) with the American Medical Association's procedural code changes (which take effect on January 1). Using new ICD-10-CM codes with outmoded procedural bundles or failing to crosswalk newly created diagnostic codes to procedural LCD coverage policies causes front-end claim suspension.
To understand how procedural codes interact with diagnostic updates, cross-reference our companion guide on CPT 2026 Code Changes: 418 Updates Explained and our checklist for avoiding Common Audit Mistakes in Medical Billing.
Exam Scenario: A patient is diagnosed with Metabolic Dysfunction-Associated Steatohepatitis with documented stage 3 bridging fibrosis confirmed by FibroScan. Option A lists K76.0; Option B lists K75.81; Option C lists K76.03; Option D lists K76.9.
The Distractor: Options A and B represent outdated or unexpanded 2025 codes. In the 2026 code set, K75.81 directs the coder to category K76.0-, where K76.03 is the only code that captures both MASH and fibrosis stage. Selecting an unexpanded 4-character code when a 5-character specific code exists is an immediate exam scoring failure.
Rule: Whenever a 4th, 5th, 6th, or 7th character is available in the Tabular List, the code is invalid for billing without it.
Eliminate hesitation between old and new codes. Drill authentic clinical encounter questions updated for the FY 2026 guidelines in our interactive practice simulator.
The 2026 ICD-10-CM codes take effect on October 1, 2025 for all dates of service through September 30, 2026, with zero grace period allowed under federal HIPAA claims transaction regulations.
NASH (Non-Alcoholic Steatohepatitis) was replaced by MASH (Metabolic Dysfunction-Associated Steatohepatitis) under subcategory K76.0-, introducing dedicated codes to distinguish MASH with and without liver fibrosis.
No, submitting a deleted ICD-10-CM code for a date of service on or after October 1 results in an immediate front-end clearinghouse rejection (ANSI-837 edit failure) and unpayable claims.
CMS expanded SDOH Z-codes under category Z59 to capture specific environmental and housing vulnerabilities, enabling accountable care organizations (ACOs) and health plans to qualify for value-based health equity benchmark payments.
AAPC exam questions align with the annual code book editions; examinees taking the exam in late 2025 and throughout 2026 are expected to navigate the FY 2026 code book and identify newly created specific subcategories over deleted unspecified codes.